Coming Soon
Find information on sensory hearing loss diagnosis, including clinical documentation, medical coding, and healthcare resources. Learn about sensorineural hearing loss, auditory neuropathy, cochlear damage, hearing thresholds, audiometry testing, and ICD-10 codes H90-H91 related to hearing impairment. Explore causes, symptoms, and treatment options for sensory neural hearing loss and improve your understanding of audiological evaluations and hearing healthcare management. This resource offers guidance for healthcare professionals on accurate diagnosis and documentation of sensory hearing loss.
Also known as
Conductive and sensorineural hearing loss
Hearing loss due to problems with both the outer/middle and inner ear.
Other hearing loss
Hearing loss not classified as conductive or sensorineural.
Other disorders of inner ear
Disorders affecting the inner ear, often related to hearing.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is hearing loss due to aging?
When to use each related code
| Description |
|---|
| Inner ear hearing loss |
| Conductive hearing loss |
| Mixed hearing loss |
Incorrect coding for right ear, left ear, or bilateral hearing loss (H90.3, H90.4, H90.5) impacting reimbursement and data accuracy.
Miscoding conductive hearing loss (H90.2) as sensorineural (H90.3-H90.5) leading to inaccurate clinical documentation and quality metrics.
Using unspecified codes (H91.9) when a more specific sensorineural hearing loss diagnosis is documented, hindering data analysis and revenue cycle.
Q: What are the most effective differential diagnostic procedures for sensorineural hearing loss in adults, differentiating it from other types of hearing loss?
A: Differentiating sensorineural hearing loss (SNHL) from other types like conductive hearing loss requires a multi-faceted approach. Pure tone audiometry is the foundational test, revealing the degree and configuration of hearing loss. However, to pinpoint SNHL specifically, clinicians should incorporate speech audiometry (evaluating speech recognition thresholds and word recognition scores), tympanometry (assessing middle ear function to rule out conductive components), and acoustic reflex testing (evaluating the stapedius muscle reflex, often absent or elevated in SNHL). Auditory brainstem response (ABR) testing can further localize the site of lesion within the auditory pathway, distinguishing cochlear from retrocochlear pathologies. For patients presenting with asymmetric SNHL, MRI is crucial to exclude acoustic neuroma or other retrocochlear lesions. Consider implementing a comprehensive test battery including these procedures to accurately diagnose SNHL and guide appropriate management. Explore how combining these tests offers a more precise diagnosis compared to relying on pure tone audiometry alone.
Q: How can I effectively counsel patients on the latest evidence-based management strategies for sensorineural hearing loss, including both amplification and non-amplification options?
A: Counseling patients with SNHL requires a patient-centered approach that considers their individual needs and preferences. While amplification with hearing aids remains the cornerstone of management for most patients, discussing both amplification and non-amplification options is essential for informed decision-making. Amplification options include traditional hearing aids, bone-anchored hearing aids (BAHAs), and cochlear implants, each with its specific indications and benefits. Non-amplification strategies include assistive listening devices (ALDs), communication strategies training, and, in specific cases, sign language. When discussing amplification, emphasize the importance of realistic expectations and the iterative process of fitting and adjustment. For patients hesitant about hearing aids, explore the benefits of ALDs and communication strategies as valuable adjuncts or alternatives. Learn more about the latest advancements in hearing aid technology, including directional microphones, noise reduction features, and Bluetooth connectivity, to effectively address patient concerns and tailor recommendations. Consider implementing a shared decision-making model to ensure patient satisfaction and optimal outcomes.
Patient presents with complaints consistent with sensory hearing loss, also known as sensorineural hearing loss SNHL. Onset of hearing difficulty was reported as gradual progressive intermittent sudden or fluctuating, impacting the patients ability to understand speech in quiet and noisy environments. Symptoms include difficulty hearing high-pitched sounds, tinnitus, and or dizziness. The patient denies experiencing ear pain, discharge, or fullness. Otoscopic examination revealed normal tympanic membranes bilaterally. Pure-tone audiometry PTA confirms the presence of sensorineural hearing loss, demonstrating thresholds exceeding dB HL at frequencies of Hz. Speech audiometry revealed a word recognition score of percent. Differential diagnoses considered include presbycusis, noise-induced hearing loss NIHL, ototoxicity, Menieres disease, acoustic neuroma, and auditory neuropathy spectrum disorder. Based on the patients history, examination, and audiometric findings, the diagnosis of sensorineural hearing loss is established. The patient was counseled on the nature and prognosis of sensorineural hearing loss, as well as management options, including hearing aids, assistive listening devices ALDs, cochlear implants, and communication strategies. Referral to an audiologist and or otolaryngologist is recommended for further evaluation and management. ICD-10 code H90. Return to clinic scheduled in weeks months for follow-up and reassessment of hearing status.